featured
Efficacy of Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Patients With Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)
Clin. Gastroenterol. Hepatol. 2024 Jul 01;22(7)1487-1496.e12, JF Colombel, RC Ungaro, BE Sands, CA Siegel, DC Wolf, JF Valentine, BG Feagan, B Neustifter, H Kadali, P Nazarey, A James, V Jairath, RM Qasim KhanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.